Neutrophils pivotal in #Behcet's syndrome pathogenesis↔️Target for therapy ▶️Infliximab superior to cyclophosphamide for induction ▶️Adalimumab superior to cyclosporin to reduce uveitis relapse via Matteo Piga #EULAR2025

Interesting work on the risk of progression of systemic sclerosis interstitial lung disease (ILD) ➡️ FVC decline in a 12 month period does not predict ILD progression in the next period ⚠️ Nevertheless, FVC decline is associated with mortality pubmed.ncbi.nlm.nih.gov/40381640/

New systematic review by Siniša Savić et al. characterises the complete phenotypic spectrum of VEXAS syndrome. ➡️These findings will facilitate earlier diagnosis, inform monitoring strategies, and guide future research priorities. ➡️bit.ly/40gp76A

First FcRn inhibitor in #IIM: In #ALKIVIA, SC efgartigimod PH20 improved TIS vs placebo at 24wks (50.45 vs 35.65, p=0.0004), with faster time to TIS≥20 (30 vs 71.5d) & TIS≥40 (113d vs NE). More major responders too (TIS>60: 34% vs 9.5%). #EULAR2025 #OP0002

ICYMI: Consensus Against Interventional Injections for Chronic Spinal Pain BMJ has published a clinical practice guideline resulting from the work of an international, multidisciplinary panel addressing chronic spine pain (≥3 months duration) not associated with cancer or

Nuestra enfermera Patricia García, habla del abordaje en la cura de las úlceras en pacientes con esclerosis sistémica. Fundamental el papel de la enfermera especializada en el cuidado de los pacientes.

Primera revisión sistemática de la literatura 📚 de George Fragoulis et al. sobre la combinación de FAMEb en enfermedades inmunomediadas (¡1200 pacientes!). Combinaciones más frecuentes: TNFi+IL/23i, JAKi+bDMARDs, y vedolizumab+TNFi. Acceso abierto 🔑 sciencedirect.com/science/articl…

🎥¡Seguimos difundiendo el conocimiento! Ya puedes ver la ponencia: “¿Qué hago con mis úlceras y calcinosis?”, a cargo de la Sra. Patricia García, enfermera de Reumatología Ramón y Cajal del Hospital Ramón y Cajal. 👉youtube.com/watch?v=8PNI0d… #aeecongreso2025 #Esclerodermia #Reumatología

Novartis announced top line results of its ianalumab (VAY736;B cell inhibitor) in primary Sjögren’s dz. 2 RCTs, NEPTUNUS-1 and NEPTUNUS-2, met met primary endpoints w/ statistically significant improvements in disease activity in Sjögren’s patients. buff.ly/c6COFPw

Two recent studies on rheumatoid arthritis associated interstitial lung disease (RA-ILD): ▶️ Review of lung ultrasound as a screening tool in RA-ILD pubmed.ncbi.nlm.nih.gov/40643573/ ▶️ Peripheral biomarker signatures in RA-ILD: analysis of the VARA registry pubmed.ncbi.nlm.nih.gov/40033001/

Subanalysis of the proDerm study: ▶️Predictors of response to IVIG: ⬆️cutaneous activity and anti-TIF1-γ➕ pubmed.ncbi.nlm.nih.gov/39918968/ ▶️Efficacy of IVIG on systemic manifestations: 🔝Skeletal, also in pulmonary, gastrointestinal and constitutional domains pubmed.ncbi.nlm.nih.gov/40616720/

Two recent articles ➡️ lung trasplant results in patients with connective tissue disease associated interstitial lung disease #ILD: ▶️Observational study, Johns Hopkins Hospital cohort, focused in #myositis pubmed.ncbi.nlm.nih.gov/40808826/ ▶️Systematic review pubmed.ncbi.nlm.nih.gov/40426174/

Update of the ATS/ERS Multidisciplinary Classification of the Interstitial Pneumonias🫁 ▶️Histological and radiological patterns (idiopathic, secondary) ▶️Interstitial vs alveolar ▶️New pattern (BIP), reclassification of old patterns (DIP➡️AMP, AIP➡️DAD) publications.ersnet.org/content/erj/ea…

Systematic review/meta-analysis ➡️treatments for rheumatoid arthritis interstitial lung disease 💊 Methotrexate ⬇️ mortality, FVC and composite progression 💊 Abatacept⬇️ HRCT and composite progression 💊 RTX/MMF/JAKi stabilize FVC #rheumatology #RAILD sciencedirect.com/science/articl…

Espero veros a todos siguiendo el #ACR25 review 🇺🇸 de Soc.Esp.Reumatología que tengo el gusto de coordinar Revisores TOP 🔝 - Roxana González ➡️ AR - María Jesús Montesa ➡️ EspA - Ana Lois ➡️ LES, Sjögren, esclerodermia - Jesús Loarce ➡️ vasculitis, miopatías - LuisCT ➡️ miscelánea

Primer día de resúmenes #ACReview25 de Soc.Esp.Reumatología que tengo el gusto de coordinar ¡Equipazo de revisores TOP! 🔝 Link 👉🏻 acr-review.ser.es

Screening for ILD in RA patients: CXR and PFTs by themselves are close to a waste of time. When it comes to screening (high-risk) RA patients, it’s HRCT (or lung USS) or nothing really. (in keeping with EULAR, ACR guidelines) #ACR25 ABST1335 Dr. John Cush

Segundo día de resúmenes #ACReview25 de Soc.Esp.Reumatología que tengo el gusto de coordinar ¡Equipazo de revisores TOP! 🔝 Link 👉🏻 acr-review.ser.es

Feliz y agradecida por haber compartido este #ACReview25 con un equipazo y una coordinación impecable. Un lujo trabajar con vosotros 💙Ana Lois María Jesús Montesa Jesús Loarce LuisCT Cristina Macía Soc.Esp.Reumatología #ACR25

Tercer día de resúmenes #ACReview25 de Soc.Esp.Reumatología que tengo el gusto de coordinar ¡Equipazo de revisores TOP! 🔝 Link 👉🏻 acr-review.ser.es